Labiana Health, S.A. (BME:LAB)

Spain flag Spain · Delayed Price · Currency is EUR
6.30
+0.05 (0.80%)
At close: Jun 26, 2026
Market Cap52.06M +102.0%
Revenue (ttm)71.67M +8.4%
Net Income904.36K
EPS0.13
Shares Out 8.26M
PE Ratio48.73
Forward PE14.07
Dividendn/a
Ex-Dividend Daten/a
Volume5,882
Open6.15
Previous Close6.25
Day's Range6.15 - 6.30
52-Week Range3.34 - 8.20
Beta0.61
Analystsn/a
Price Targetn/a
Earnings DateApr 21, 2026

About Labiana Health

Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms, bacterial vaccines and biological formats; and Fosfomycin trometamol under the Fosfomicina Labiana brand name. In addition, the company offers contrac... [Read more]

Sector Healthcare
Founded 1958
Employees 394
Stock Exchange Madrid Stock Exchange
Ticker Symbol LAB
Full Company Profile

Financial Performance

Financial Statements